// App-Quantinova.ai

: Movement Disorder Specialists’ Determination of Eligibility for Device Aided Treatment in Advanced Parkinson’s Disease: Results from the OBSERVE-PD Study (P5.069)

Researchers

Presenter

  • Alfonso Fasano

Principal Investigators

  • Klaus Seppi

  • Victor Fung

  • Juan Carlos Parra

  • Lars Bergmann

  • Kavita Sail

  • Yash Jalundhwala

  • Koray Onuk

Medical Centers

  • 3Westmead Hospital and Sydney Medical School Sydney Australia

  • Toronto Western Hospital - U of Toronto Toronto ON Canada

  • Medical University Innsbruck, Innsbruck, Austria

  • AbbVie Inc., North Chicago, Illinois, United States

Locations

  • Australia

  • Canada

  • Austria

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Carbidopa and Levodopa

  • Apomorphine

  • Carbidopa

  • Levodopa

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved